These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29509590)

  • 1. Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.
    Wools-Kaloustian K; Marete I; Ayaya S; Sohn AH; Van Nguyen L; Li S; Leroy V; Musick BS; Newman JE; Edmonds A; Davies MA; Eboua FT; Obama MT; Yotebieng M; Sawry S; Mofenson LM; Yiannoutsos CT
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):221-230. PubMed ID: 29509590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    Clin Infect Dis; 2018 Feb; 66(4):594-603. PubMed ID: 29029056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand.
    Teeraananchai S; Bunupuradah T; Puthanakit T; Kerr SJ; Ruxrungtham K; Chaivooth S; Bhakeecheep S; Law MG; Chokephaibulkit K
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):219-225. PubMed ID: 28498146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
    Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis.
    Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
    J Int AIDS Soc; 2020 Apr; 23(4):e25477. PubMed ID: 32297485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
    Desmonde S; Eboua FT; Malateste K; Dicko F; Ekouévi DK; Ngbeché S; Koueta F; Sy HS; Renner L; Koumakpai SA; Leroy V;
    AIDS; 2015 Jul; 29(12):1527-36. PubMed ID: 26244392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
    PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
    Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
    Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
    Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
    Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa.
    ;
    J Int AIDS Soc; 2011 Feb; 14():7. PubMed ID: 21306608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
    AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).
    Giles ML; Achhra AC; Abraham AG; Haas AD; Gill MJ; Lee MP; Luque M; McGowan C; Cornell M; Braitstein P; de Rekeneire N; Becquet R; Wools-Kaloustian K; Law M
    J Int AIDS Soc; 2018 Jun; 21(6):e25149. PubMed ID: 29956882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Chang LW; Harris J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.